BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38278669)

  • 1. Type 2 diabetes-related health measures during the initial COVID-19 surge at an academic internal medicine practice.
    Ma L; Diaz J; Deconde J; Wong M; Ruo B
    Prim Care Diabetes; 2024 Apr; 18(2):246-247. PubMed ID: 38278669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in clinic visits and diabetes and metabolic control in patients with type 2 diabetes during COVID-19 pandemic: A real world evidence.
    Bandarian F; Qorbani M; Aalaa M; Peimani M; Larijani B; Nasli-Esfahani E
    Prim Care Diabetes; 2023 Jun; 17(3):238-241. PubMed ID: 36935271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of COVID-19 fear, treatment compliance, and metabolic control of patients with type 2 diabetes mellitus during the pandemic.
    Menekli T; Yaprak B; Türeyen A; Şentürk S
    Prim Care Diabetes; 2022 Oct; 16(5):658-663. PubMed ID: 36030171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes and COVID-19: The past, the present, and the future.
    Pranata R; Henrina J; Raffaello WM; Lawrensia S; Huang I
    Metabolism; 2021 Aug; 121():154814. PubMed ID: 34119537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The indirect impact of the COVID-19 pandemic on people with type 2 diabetes mellitus and without COVID-19 infection: Systematic review and meta-analysis.
    Hu Z; Youn HM; Quan J; Lee LLS; Mak IL; Yu EYT; Chao DV; Ko WWK; Wong ICK; Lau GKK; Lau CS; Lam CLK; Wan EYF
    Prim Care Diabetes; 2023 Jun; 17(3):229-237. PubMed ID: 36872178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of point-of-care screening for type 2 diabetes mellitus and hypertension into the COVID-19 vaccine programme in Johannesburg, South Africa.
    Brennan AT; Vetter B; Masuku SD; Mtshazo B; Mashabane N; Sokhela S; Venter WD; Kao K; Meyer-Rath G
    BMC Public Health; 2023 Nov; 23(1):2291. PubMed ID: 37986070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sedentariness and physical activity in type 2 diabetes during the COVID-19 pandemic.
    Balducci S; Coccia EM
    Diabetes Metab Res Rev; 2021 Feb; 37(2):e3378. PubMed ID: 32592519
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of remote management on comprehensive management of diabetes mellitus during the COVID-19 epidemic.
    Kang J; Chen Y; Zhao Y; Zhang C
    Prim Care Diabetes; 2021 Jun; 15(3):417-423. PubMed ID: 33422431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycemic parameters in patients with new-onset diabetes during COVID-19 pandemic are more severe than in patients with new-onset diabetes before the pandemic: NOD COVID India Study.
    Ghosh A; Anjana RM; Shanthi Rani CS; Jeba Rani S; Gupta R; Jha A; Gupta V; Kuchay MS; Luthra A; Durrani S; Dutta K; Tyagi K; Unnikrishnan R; Srivastava BK; Ramu M; Sastry NG; Gupta PK; Umasankari G; Jayashri R; Mohan V; Misra A
    Diabetes Metab Syndr; 2021; 15(1):215-220. PubMed ID: 33450530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of a telehealth intervention on the metabolic profile of diabetes mellitus patients during the COVID-19 pandemic - A randomized clinical trial.
    Franco DW; Alessi J; de Carvalho TR; Kobe GL; Oliveira GB; Knijnik CP; Amaral B; Becker AS; Schaan BD; Telo GH
    Prim Care Diabetes; 2022 Dec; 16(6):745-752. PubMed ID: 36266163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 pandemic: Effects of national lockdown on the state of health of patients with type 2 diabetes mellitus in a Moroccan population.
    Farhane H; Motrane M; Anaibar FE; Motrane A; Abeid SN; Harich N
    Prim Care Diabetes; 2021 Oct; 15(5):772-777. PubMed ID: 34172426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the COVID-19 pandemic on the glycemic control in people with diabetes mellitus: A retrospective cohort study.
    Ohkuma K; Sawada M; Aihara M; Doi S; Sekine R; Usami S; Ohe K; Kubota N; Yamauchi T
    J Diabetes Investig; 2023 Aug; 14(8):985-993. PubMed ID: 37118898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indirect effects of the COVID-19 pandemic on people with type 2 diabetes: time to urgently move into a recovery phase.
    Vamos EP; Khunti K
    BMJ Qual Saf; 2022 Jul; 31(7):483-485. PubMed ID: 34686562
    [No Abstract]   [Full Text] [Related]  

  • 14. COVID-19 hinterland: surveilling the self-reported impacts of the pandemic on diabetes management in the USA (cross-sectional results of the iNPHORM study).
    Ratzki-Leewing AA; Ryan BL; Buchenberger JD; Dickens JW; Black JE; Harris SB
    BMJ Open; 2021 Sep; 11(9):e049782. PubMed ID: 34475174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telemedicine management of type 2 diabetes mellitus in obese and overweight young and middle-aged patients during COVID-19 outbreak: A single-center, prospective, randomized control study.
    Yin W; Liu Y; Hu H; Sun J; Liu Y; Wang Z
    PLoS One; 2022; 17(9):e0275251. PubMed ID: 36174028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparities in Telemedicine Use for Subspecialty Diabetes Care During COVID-19 Shelter-In-Place Orders.
    Haynes SC; Kompala T; Neinstein A; Rosenthal J; Crossen S
    J Diabetes Sci Technol; 2021 Sep; 15(5):986-992. PubMed ID: 33719622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes and CoViD-19: Experience from the frontline of Internal Medicine wards in Italy.
    Montagnani A; Pieralli F; Gnerre P; Pomero F; Campanini M; Dentali F; Fontanella A; Manfellotto D;
    Diabetes Res Clin Pract; 2020 Sep; 167():108335. PubMed ID: 32687955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of telemedicine on patients with uncontrolled type 2 diabetes mellitus during the COVID-19 pandemic in Saudi Arabia: Findings and implications.
    M Tourkmani A; J ALHarbi T; Rsheed AMB; Alrasheedy AA; ALMadani W; ALJuraisi F; AlOtaibi AF; AlHarbi M; AlAbood AF; Alshaikh AA
    J Telemed Telecare; 2023 Jun; 29(5):390-398. PubMed ID: 33525952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the COVID-19 pandemic on new diagnoses of type 2 diabetes in England.
    Barron E; Khunti K; Wright AK; Ashcroft DM; Carr MJ; Rutter MK; Valabhji J
    Diabetes Obes Metab; 2023 Nov; 25(11):3424-3429. PubMed ID: 37489091
    [No Abstract]   [Full Text] [Related]  

  • 20. Telehealth use and its impact on clinical outcomes in patients with type 2 diabetes during the COVID-19 pandemic.
    Shao Y; Shi L; Nauman E; Price-Haywood E; Stoecker C
    Diabetes Obes Metab; 2024 Jan; 26(1):118-125. PubMed ID: 37726978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.